Latest Breaking News On - Michael petusky - Page 1 : vimarsana.com

SRDX Alert: Monsey Firm of Wohl & Fruchter Investigating

We are investigating the fairness of the sale of Surmodics to GTCR for $43.00 per share in cash.

Opko Health (OPK) Q1 2024 Earnings Call Transcript

Critical Insights From OPKO Health Analyst Ratings: What You Need To Know

Across the recent three months, 4 analysts have shared their insights on OPKO Health (NASDAQ:OPK), expressing a variety of opinions spanning from .

Buy Rating Affirmed for Opko Health Amid Strategic Divestiture and Operational Improvement Prospects

In a report released today, Michael Petusky from Barrington maintained a Buy rating on Opko Health (OPK – Research Report), with a price t.

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q4 2023 Earnings Call Transcript

LeMaitre Vascular, Inc. beats earnings expectations. Reported EPS is $0.38, expectations were $0.36. LeMaitre Vascular, Inc.